Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: April 28, 2017

DrugPatentWatch Database Preview

Tolbutamide - Generic Drug Details

« Back to Dashboard

What are the generic sources for tolbutamide and what is the scope of patent protection?

Tolbutamide
is the generic ingredient in three branded drugs marketed by Watson Labs, Barr, Dava Pharms Inc, Alra, Ascot, Mylan Pharms Inc, Parke Davis, Purepac Pharm, Pharmacia And Upjohn, Sandoz, Vangard, Ivax Pharms, and Superpharm, and is included in eighteen NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are fifteen drug master file entries for tolbutamide. One supplier is listed for this compound.

Summary for Generic Name: tolbutamide

Tradenames:3
Patents:1
Applicants:13
NDAs:18
Drug Master File Entries: see list15
Suppliers / Packagers: see list1
Bulk Api Vendors: see list65
Clinical Trials: see list11
Patent Applications: see list6,216
Therapeutic Class:Blood Glucose Regulators
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:tolbutamide at DailyMed

Pharmacology for Ingredient: tolbutamide

Ingredient-typeSulfonylurea Compounds
Drug ClassSulfonylurea
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pharmacia And Upjohn
ORINASE
tolbutamide
TABLET;ORAL010670-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Alra
TOLBUTAMIDE
tolbutamide
TABLET;ORAL086141-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Pharmacia And Upjohn
ORINASE DIAGNOSTIC
tolbutamide sodium
INJECTABLE;INJECTION012095-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Mylan Pharms Inc
TOLBUTAMIDE
tolbutamide
TABLET;ORAL086445-001Approved Prior to Jan 1, 1982RXNoYes► Subscribe► Subscribe
Ivax Pharms
TOLBUTAMIDE
tolbutamide
TABLET;ORAL087093-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Predict branded drug patent expiration
  • Identify first generic entrants
  • Uncover prior art in abandoned patent applications and expired patents

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot